TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 60 filers reported holding TAYSHA GENE THERAPIES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $433 | -63.2% | 137 | -92.3% | 0.00% | – |
| Q2 2023 | $1,178 | +17.8% | 1,782 | 0.0% | 0.00% | – |
| Q1 2023 | $1,000 | +24900.0% | 1,782 | 0.0% | 0.00% | – |
| Q4 2022 | $4 | -100.0% | 1,782 | -96.0% | 0.00% | – |
| Q3 2022 | $86,000 | -91.7% | 44,558 | -84.0% | 0.00% | – |
| Q2 2022 | $1,039,000 | -63.8% | 279,291 | -36.5% | 0.00% | – |
| Q1 2022 | $2,868,000 | +3.6% | 439,804 | +85.1% | 0.00% | – |
| Q4 2021 | $2,768,000 | -64.6% | 237,559 | -43.5% | 0.00% | -100.0% |
| Q3 2021 | $7,827,000 | +72.9% | 420,362 | +96.8% | 0.00% | 0.0% |
| Q2 2021 | $4,528,000 | +751.1% | 213,646 | +714.7% | 0.00% | – |
| Q1 2021 | $532,000 | -15.6% | 26,223 | +10.4% | 0.00% | – |
| Q4 2020 | $630,000 | – | 23,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 3,827,926 | $12,096,246 | 8.11% |
| TCG Crossover Management, LLC | 11,111,111 | $35,111,111 | 5.17% |
| VR Adviser, LLC | 14,444,444 | $45,644,443 | 4.80% |
| Kynam Capital Management, LP | 3,281,313 | $10,368,949 | 1.70% |
| Ghost Tree Capital, LLC | 1,325,000 | $4,187,000 | 1.38% |
| Octagon Capital Advisors LP | 2,777,778 | $8,777,778 | 1.35% |
| RA Capital Management | 18,472,503 | $58,373,109 | 1.15% |
| RTW INVESTMENTS, LP | 16,893,185 | $53,382,465 | 1.13% |
| Diametric Capital, LP | 760,014 | $2,401,644 | 1.00% |
| Quantum Private Wealth, LLC | 575,380 | $1,818,201 | 0.87% |